Cargando…

278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment

BACKGROUND: Blastomycosis is a systemic infection, well known to regions of the Southeastern and Ohio River Basin in the United States. Inhalation of the dimorphic fungus most often causes pulmonary manifestations. Hematogenous dissemination can affect various organs in immunocompromised hosts. Cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Majdick, Kathryn, Kaye, Keaton, Shorman, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810459/
http://dx.doi.org/10.1093/ofid/ofz360.353
_version_ 1783462260686979072
author Majdick, Kathryn
Kaye, Keaton
Shorman, Mahmoud
author_facet Majdick, Kathryn
Kaye, Keaton
Shorman, Mahmoud
author_sort Majdick, Kathryn
collection PubMed
description BACKGROUND: Blastomycosis is a systemic infection, well known to regions of the Southeastern and Ohio River Basin in the United States. Inhalation of the dimorphic fungus most often causes pulmonary manifestations. Hematogenous dissemination can affect various organs in immunocompromised hosts. Central Nervous System (CNS) involvement is a rare manifestation of Blastomycosis infection, accounting for 5%–10% of extrapulmonary involvement. It is important to diagnosis early and treat due to the increased morbidity in high-risk patients. METHODS: Our study retrospectively reviewed cases from a Tertiary Care Facility in East Tennessee from 2011 to 2018 with the diagnosis of CNS Blastomycosis. Data collection included demographics, risk factors, varied clinical presentation, methods of diagnosis, treatment plans and outcomes. RESULTS: Total of 8 CNS Blastomycosis cases were identified. Detailed demographics are presented in Table 1. The average age was 52 years, 7 (87.5%) were male. 6 (75%) were classified as immunocompromised. 6 of the 8 cases were tested for HIV, all of which were negative. MRI brain imaging was utilized in 7 (87.5%) cases, which demonstrated lesion enhancements, Table 2 and Images 1 and 2. CSF was collected in 6 (75%) patients. 5 patients (62%) presented with neurological complaints. All patients received Liposomal Amphotericin B (LAmpB), followed by a prolonged course of azoles. 5 (62%) developed acute renal insufficiency after starting Amphotericin B. 2 (25%) died. CONCLUSION: CNS Blastomycosis is a rare diagnosis with increased morbidity and mortality. Obtaining brain imaging in addition to lumbar puncture can help in timely diagnosis of CNS Blastomycosis. Treatment involves lipid formulation of Amphotericin B followed by oral azole therapy, preferably voriconazole. Renal insufficiency was a common finding after this treatment. A high level of suspicion is crucial for recognition of CNS Blastomycosis in endemic regions of the Southeastern and Ohio River Basin. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810459
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68104592019-10-28 278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment Majdick, Kathryn Kaye, Keaton Shorman, Mahmoud Open Forum Infect Dis Abstracts BACKGROUND: Blastomycosis is a systemic infection, well known to regions of the Southeastern and Ohio River Basin in the United States. Inhalation of the dimorphic fungus most often causes pulmonary manifestations. Hematogenous dissemination can affect various organs in immunocompromised hosts. Central Nervous System (CNS) involvement is a rare manifestation of Blastomycosis infection, accounting for 5%–10% of extrapulmonary involvement. It is important to diagnosis early and treat due to the increased morbidity in high-risk patients. METHODS: Our study retrospectively reviewed cases from a Tertiary Care Facility in East Tennessee from 2011 to 2018 with the diagnosis of CNS Blastomycosis. Data collection included demographics, risk factors, varied clinical presentation, methods of diagnosis, treatment plans and outcomes. RESULTS: Total of 8 CNS Blastomycosis cases were identified. Detailed demographics are presented in Table 1. The average age was 52 years, 7 (87.5%) were male. 6 (75%) were classified as immunocompromised. 6 of the 8 cases were tested for HIV, all of which were negative. MRI brain imaging was utilized in 7 (87.5%) cases, which demonstrated lesion enhancements, Table 2 and Images 1 and 2. CSF was collected in 6 (75%) patients. 5 patients (62%) presented with neurological complaints. All patients received Liposomal Amphotericin B (LAmpB), followed by a prolonged course of azoles. 5 (62%) developed acute renal insufficiency after starting Amphotericin B. 2 (25%) died. CONCLUSION: CNS Blastomycosis is a rare diagnosis with increased morbidity and mortality. Obtaining brain imaging in addition to lumbar puncture can help in timely diagnosis of CNS Blastomycosis. Treatment involves lipid formulation of Amphotericin B followed by oral azole therapy, preferably voriconazole. Renal insufficiency was a common finding after this treatment. A high level of suspicion is crucial for recognition of CNS Blastomycosis in endemic regions of the Southeastern and Ohio River Basin. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810459/ http://dx.doi.org/10.1093/ofid/ofz360.353 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Majdick, Kathryn
Kaye, Keaton
Shorman, Mahmoud
278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment
title 278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment
title_full 278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment
title_fullStr 278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment
title_full_unstemmed 278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment
title_short 278. CNS Blastomycosis: A Descriptive Analysis and Review of Diagnosis and Treatment
title_sort 278. cns blastomycosis: a descriptive analysis and review of diagnosis and treatment
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810459/
http://dx.doi.org/10.1093/ofid/ofz360.353
work_keys_str_mv AT majdickkathryn 278cnsblastomycosisadescriptiveanalysisandreviewofdiagnosisandtreatment
AT kayekeaton 278cnsblastomycosisadescriptiveanalysisandreviewofdiagnosisandtreatment
AT shormanmahmoud 278cnsblastomycosisadescriptiveanalysisandreviewofdiagnosisandtreatment